- Home
- FMAO vs PROC Comparison
FMAO vs PROC Comparison
Compare FMAO & PROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMAO
- PROC
- Stock Information
- Founded
- FMAO 1897
- PROC 1976
- Country
- FMAO United States
- PROC Luxembourg
- Employees
- FMAO N/A
- PROC N/A
- Industry
- FMAO Savings Institutions
- PROC Biotechnology: Pharmaceutical Preparations
- Sector
- FMAO Finance
- PROC Health Care
- Exchange
- FMAO Nasdaq
- PROC Nasdaq
- Market Cap
- FMAO 290.9M
- PROC 203.1M
- IPO Year
- FMAO N/A
- PROC N/A
- Fundamental
- Price
- FMAO $27.39
- PROC $1.92
- Analyst Decision
- FMAO Hold
- PROC
- Analyst Count
- FMAO 2
- PROC 0
- Target Price
- FMAO $26.00
- PROC N/A
- AVG Volume (30 Days)
- FMAO 17.0K
- PROC 11.6K
- Earning Date
- FMAO 10-28-2024
- PROC 11-12-2024
- Dividend Yield
- FMAO 3.16%
- PROC N/A
- EPS Growth
- FMAO N/A
- PROC N/A
- EPS
- FMAO 1.56
- PROC 0.52
- Revenue
- FMAO $95,411,000.00
- PROC $414,096,000.00
- Revenue This Year
- FMAO N/A
- PROC $5.54
- Revenue Next Year
- FMAO $7.89
- PROC $8.54
- P/E Ratio
- FMAO $18.03
- PROC $3.72
- Revenue Growth
- FMAO N/A
- PROC N/A
- 52 Week Low
- FMAO $16.90
- PROC $1.68
- 52 Week High
- FMAO $28.76
- PROC $4.95
- Technical
- Relative Strength Index (RSI)
- FMAO 52.40
- PROC 43.98
- Support Level
- FMAO $25.93
- PROC $1.77
- Resistance Level
- FMAO $28.76
- PROC $2.06
- Average True Range (ATR)
- FMAO 0.64
- PROC 0.11
- MACD
- FMAO 0.11
- PROC -0.02
- Stochastic Oscillator
- FMAO 57.19
- PROC 25.86
About FMAO Farmers & Merchants Bancorp Inc.
Farmers & Merchants Bancorp Inc is a holding company for Farmers & Merchants Bank of Central California. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.
About PROC Procaps Group S.A.
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.